Trial Profile
Comparison of multifield radiotherapy and rituximab IV in the treatment of indolent B-cell lymphomas cutaneous lesions has multiple or recurrent [Comparaison de la radiotherapie multichamps et du rituximab IV dans le traitement des lymphomes B cutanes indolents a lesions multiples ou recidivantes].
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2014
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 02 Aug 2014 New trial record
- 02 Aug 2014 New trial record